Ryutaro Matsuhashi Email

VP -Latin America . Certis Biologicals

Current Roles

Employees:
177
Revenue:
$27.4M
About
Certis Biologicals is a pioneer in the development of biological pesticides and has become one of the world’s leading manufacturers and distributors of biopesticides. We specialize in: Biological product development, from screening to formulation to field development Manufacturing: fermentation and formulation Global registrations for biological products Global sales channels. We export to more than 30 countries. Certis Biologicals traces its roots to some of the early leaders in the development of biological and botanical pesticides, beginning with the formation of Thermo Trilogy in 1996 and the acquisition of Neem Technologies from W.R. Grace. Since then, the company has grown by identifying and acquiring products that complement its product line. These include baculovirus products acquired from Biosys in 1997 and Bt bioinsecticide products acquired from Novartis in 1997 and Ecogen in 2002. In 2001, Mitsui & Co., a leading Japanese trading company, acquired Thermo Trilogy and renamed it Certis U.S.A. L.L.C. Within Mitsui's AgriScience Division, Certis Biologicals is positioned as the global competence center for biological control technologies. Today the company’s product line represents some of finest bioproducts and active ingredients in the industry.
Certis Biologicals Address
9145 Guilford Road
Columbia, MD
United States
Certis Biologicals Email

Past Companies

Certis Agro Mexico, S. de R.L. de C.V.Chairman and President
Certis BiologicalsVice President -Latin America and Corporate Secretary
Certis USAVice President International

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.